Carona
In the Sep 2025 quarter, revenue was ₹34.85 Cr and net profit was ₹3.38 Cr. Promoters held 63.68% of Carona in Oct 2025.
Peer Comparison
Consumer Discretionary › Consumer Durables › Footwear
| ₹822.25 | 55.11 | 22,415 Cr | 10.72 | 0.71% | 20.52% | 19.58% | 3,133 Cr | 412 Cr | |
| ₹659.05 | 57.96 | 8,471 Cr | 5.31 | 3.77% | 8.41% | 11.23% | 3,633 Cr | 146 Cr | |
| ₹278.35 | 37.36 | 6,929 Cr | 3.14 | 1.26% | 8.13% | 10.79% | 2,801 Cr | 186 Cr | |
| ₹190.97 | 37.89 | 5,838 Cr | 6.44 | 0.81% | 25.20% | 32.89% | 1,398 Cr | 154 Cr | |
| ₹104.84 | 23.56 | 5,796 Cr | 5.67 | 1.92% | 23.55% | 29.37% | 2,514 Cr | 247 Cr | |
| ₹260.00 | 18.35 | 602 Cr | 1.21 | 0.78% | 5.77% | 7.54% | 265 Cr | 33 Cr | |
| ₹193.10 | 38.47 | 329 Cr | 1.41 | 1.29% | 3.94% | 14.49% | 738 Cr | 9 Cr | |
Carona (this company) | — | — | — | — | — | — | — | 35 Cr | 3 Cr |
| Median 8 companies | ₹260.00 | 37.89 | 5,838 Cr | 5.31 | 1.26% | 8.41% | 14.49% | 1,956 Cr | 150 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Weaknesses
2- Company has low interest coverage ratio.
- Company has high debtors of 279 days.
Growth Rate
change over 1 year
change over 1 year
Quarterly Results
| Particulars | Sep 2025 |
|---|---|
| Sales | 34.85 |
| Expenses | 27.1 |
| Operating Profit | 7.75 |
| OPM % | 22.24% |
| Other Income | 0.1 |
| Interest | 1.24 |
| Depreciation | 1.67 |
| PBT | 4.94 |
| Tax % | 31.58% |
| Net Profit | 3.38 |
| EPS (₹) | 2.34 |
Profit & Loss
| Particulars | Mar 2006 | Mar 2007 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1.28 | 1.19 | 1.14 | 0.68 | 0.34 | 0.28 | 0.45 | 0.72 |
| Expenses | 2.01 | 1.77 | 1.5 | 1 | 0.75 | 1.22 | 0.77 | 0.94 |
| Operating Profit | -0.73 | -0.58 | -0.36 | -0.32 | -0.41 | -0.94 | -0.32 | -0.22 |
| OPM % | -57.03% | -48.74% | -31.58% | -47.06% | -120.59% | -335.71% | -71.11% | -30.56% |
| Other Income | 0.95 | 3.19 | 0.84 | 0.69 | 0.65 | 0.24 | 0 | 0 |
| Interest | 0.12 | 0.08 | 0.12 | 0.12 | 0.14 | 0 | 0 | 0 |
| Depreciation | 0 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.09 |
| PBT | 0.1 | 2.47 | 0.3 | 0.19 | 0.04 | -0.76 | -0.38 | -0.31 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | 0.1 | 2.47 | 0.29 | 0.19 | 0.03 | -0.76 | -0.39 | -0.31 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2006 | Mar 2007 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8.21 | 8.21 | 8.21 | 8.21 | 8.21 | 8.21 | 8.21 | 8.21 |
| Reserves | -36.21 | -33.74 | -32.99 | -32.8 | -32.76 | -33.52 | -33.9 | -34.21 |
| Borrowings | 10.54 | 9.33 | 9.58 | 9.62 | 9.8 | 4.71 | 5.76 | 5.76 |
| Other Liabilities | 30.72 | 29.77 | 29.47 | 29.39 | 29.44 | 35.2 | 35.02 | 35.33 |
| Total Liabilities | 13.26 | 13.57 | 14.27 | 14.42 | 14.69 | 14.6 | 15.09 | 15.09 |
| Fixed Assets | 4.19 | 4.14 | 4.22 | 4.15 | 4.09 | 4.03 | 4.28 | 4.22 |
| CWIP | 0.01 | 0.01 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Investments | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0 | 0 | 0 |
| Other Assets | 8.55 | 8.91 | 9.54 | 9.75 | 10.08 | 10.56 | 10.8 | 10.86 |
| Total Assets | 13.26 | 13.57 | 14.27 | 14.42 | 14.69 | 14.6 | 15.09 | 15.09 |
Cash Flow
| Particulars | Mar 2006 | Mar 2007 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 |
|---|---|---|---|---|---|---|---|---|
| Operating | — | — | — | — | — | -3.91 | 0.14 | -0.17 |
| Investing | — | — | — | — | — | 0 | 0.7 | 0.05 |
| Financing | — | — | — | — | — | 4.04 | 0.48 | 0.25 |
| Net Cash Flow | — | — | — | — | — | 0.13 | 1.32 | 0.13 |
| Free Cash Flow | — | — | — | — | — | -3.91 | 0.45 | -0.14 |
| CFO/EBITDA | — | — | — | — | — | 416 | -44 | 77 |
Ratios
| Particulars | Mar 2006 | Mar 2007 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 157 | 169 | 176 | 295 | 590 | 717 | 446 | 279 |
| Inventory Days | 186 | 169 | 163 | 201 | 402 | 438 | 365 | 230 |
| Days Payable | 10,386 | 11,442 | 16,060 | 26,809 | 53,728 | 47,541 | 43,757 | 27,618 |
| Cash Conversion Cycle | -10,043 | -11,104 | -15,720 | -26,313 | -52,736 | -46,386 | -42,946 | -27,110 |
| Working Capital Days | -6,405 | -6,460 | -6,429 | -10,617 | -20,869 | -34,532 | -21,000 | -13,150 |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Carona insights
28 extracted metrics + investor summaries across FY06–FY26.
Documents
Frequently Asked Questions about Carona
Where is Carona Ltd (509495) listed?
Which sector does Carona Ltd belong to?
Company Information
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/509495.md for Carona Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.